| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |